Exact Mass: 481.081602

Exact Mass Matches: 481.081602

Found 85 metabolites which its exact mass value is equals to given mass value 481.081602, within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error 0.01 dalton.

Yersiniabactin

Yersiniabactin

C21H27N3O4S3 (481.1163622000001)


A member of the class of thiazolidines that is (4S)-4-methyl-4,5-dihydro-1,3-thiazole-4-carboxylic acid which is substituted at position 2 by a (1S)-1-hydroxy-1-{(4R)-2-[(4R)-2-(2-hydroxyphenyl)-4,5-dihydro-1,3-thiazol-4-yl]-1,3-thiazolidin-4-yl}-2-methylpropan-2-yl group. A siderophore found in the gram-negative bacterium species, Yersinia enterocolitica and Yersinia pestis. D064449 - Sequestering Agents > D002614 - Chelating Agents > D007502 - Iron Chelating Agents

   

Talampicillin

4-Thia-1-azabicyclo[3.2.0]heptane-2-carboxylicacid, 6-[[(2R)-2-amino-2-phenylacetyl]amino]-3,3-dimethyl-7-oxo-,1,3-dihydro-3-oxo-1-isobenzofuranyl ester, (2S,5R,6R)-

C24H23N3O6S (481.13074980000005)


J - Antiinfectives for systemic use > J01 - Antibacterials for systemic use > J01C - Beta-lactam antibacterials, penicillins > J01CA - Penicillins with extended spectrum D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D047090 - beta-Lactams D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D010406 - Penicillins D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D007769 - Lactams C254 - Anti-Infective Agent > C258 - Antibiotic > C260 - Beta-Lactam Antibiotic Same as: D08557

   

N-(2,2,2-Trifluoroethyl)-N-{4-[2,2,2-trifluoro-1-hydroxy-1-(trifluoromethyl)ethyl]phenyl}benzenesulfonamide

N-(2,2,2-trifluoroethyl)-N-[4-[2,2,2-trifluoro-1-hydroxy-1-(trifluoromethyl)ethyl]phenyl]-benzenesulfonamide

C17H12F9NO3S (481.0394150000001)


T0901317 is an orally active and highly selective LXR agonist with an EC50 of 20 nM for LXRα[1]. T0901317 activates FXR with an EC50 of 5 μM[2]. T0901317 is RORα and RORγ dual inverse agonist with Ki values of 132 nM and 51 nM, respectively[3]. T0901317 induces apoptosis and inhibits the development of atherosclerosis in low-density lipoprotein (LDL) receptor-deficient mice[4][5].

   

T0901317

N-(2,2,2-Trifluoroethyl)-N-{4-[2,2,2-trifluoro-1-hydroxy-1-(trifluoromethyl)ethyl]phenyl}benzenesulfonamide

C17H12F9NO3S (481.0394150000001)


T0901317 is an orally active and highly selective LXR agonist with an EC50 of 20 nM for LXRα[1]. T0901317 activates FXR with an EC50 of 5 μM[2]. T0901317 is RORα and RORγ dual inverse agonist with Ki values of 132 nM and 51 nM, respectively[3]. T0901317 induces apoptosis and inhibits the development of atherosclerosis in low-density lipoprotein (LDL) receptor-deficient mice[4][5].

   

6-(Methylsulfonyl)hexyl glucosinolate

{[(e)-(7-methanesulphonyl-1-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]sulphanyl}heptylidene)amino]oxy}sulphonic acid

C14H27NO11S3 (481.0746192)


6-(Methylsulfonyl)hexyl glucosinolate is present in crucifers. Present in crucifers

   

Talampicillin

2-Amino-N-(3,3-dimethyl-7-oxo-2-{[(3-oxo-1,3-dihydro-2-benzofuran-1-yl)oxy]carbonyl}-4-thia-1-azabicyclo[3.2.0]heptan-6-yl)-2-phenylethanimidate

C24H23N3O6S (481.13074980000005)


   

Yersiniabactin

2-(1-hydroxy-1-{2-[2-(2-hydroxyphenyl)-4,5-dihydro-1,3-thiazol-4-yl]-1,3-thiazolidin-4-yl}-2-methylpropan-2-yl)-4-methyl-4,5-dihydro-1,3-thiazole-4-carboxylic acid

C21H27N3O4S3 (481.1163622000001)


   

Glucomalcomiin

3-Benzoyloxypropyl glucosinolate

C17H23NO11S2 (481.0712488)


Acquisition and generation of the data is financially supported by the Max-Planck-Society

   

Glucobenzosisymbrin

2-Benzoyloxy-1-methylethyl glucosinolate

C17H23NO11S2 (481.0712488)


   
   

3-Hydroxy-6-(methylsulfinyl)hexyl glucosinolate

3-Hydroxy-6-(methylsulfinyl)hexyl glucosinolate

C14H27NO11S3 (481.0746192)


   

2-(4-Methoxyphenyl)-2,2-dimethylethyl glucosinolate

2-(4-Methoxyphenyl)-2,2-dimethylethyl glucosinolate

C18H27NO10S2 (481.10763219999995)


   

6-Hydroxydelphinidin 3-glucoside

2- (3,4,5-Trihydroxyphenyl) -3- (beta-D-glucopyranosyloxy) -5,6,7-trihydroxy-1-benzopyrylium

C21H21O13 (481.0982116)


   

4-(3-Chloro-2-cyanophenoxy)-N-[4-(2-methyl-1,3-thiazol-4-yl)phenyl]benzenesulfonamide

4-(3-Chloro-2-cyanophenoxy)-N-[4-(2-methyl-1,3-thiazol-4-yl)phenyl]benzenesulfonamide

C23H16ClN3O3S2 (481.03215760000006)


   

Cys Cys Glu Gln

(4S)-4-[(2R)-2-[(2R)-2-amino-3-sulfanylpropanamido]-3-sulfanylpropanamido]-4-{[(1S)-3-carbamoyl-1-carboxypropyl]carbamoyl}butanoic acid

C16H27N5O8S2 (481.13009819999996)


   

Cys Cys Gln Glu

(2S)-2-[(2S)-2-[(2R)-2-[(2R)-2-amino-3-sulfanylpropanamido]-3-sulfanylpropanamido]-4-carbamoylbutanamido]pentanedioic acid

C16H27N5O8S2 (481.13009819999996)


   

Cys Asp Met Asn

(3S)-3-[(2R)-2-amino-3-sulfanylpropanamido]-3-{[(1S)-1-{[(1S)-2-carbamoyl-1-carboxyethyl]carbamoyl}-3-(methylsulfanyl)propyl]carbamoyl}propanoic acid

C16H27N5O8S2 (481.13009819999996)


   

Cys Asp Asn Met

(3S)-3-[(2R)-2-amino-3-sulfanylpropanamido]-3-{[(1S)-2-carbamoyl-1-{[(1S)-1-carboxy-3-(methylsulfanyl)propyl]carbamoyl}ethyl]carbamoyl}propanoic acid

C16H27N5O8S2 (481.13009819999996)


   

Cys Glu Cys Gln

(2S)-2-[(2R)-2-[(2S)-2-[(2R)-2-amino-3-sulfanylpropanamido]-4-carboxybutanamido]-3-sulfanylpropanamido]-4-carbamoylbutanoic acid

C16H27N5O8S2 (481.13009819999996)


   

Cys Glu Gln Cys

(4S)-4-[(2R)-2-amino-3-sulfanylpropanamido]-4-{[(1S)-3-carbamoyl-1-{[(1R)-1-carboxy-2-sulfanylethyl]carbamoyl}propyl]carbamoyl}butanoic acid

C16H27N5O8S2 (481.13009819999996)


   

Cys Met Asp Asn

(3S)-3-[(2S)-2-[(2R)-2-amino-3-sulfanylpropanamido]-4-(methylsulfanyl)butanamido]-3-{[(1S)-2-carbamoyl-1-carboxyethyl]carbamoyl}propanoic acid

C16H27N5O8S2 (481.13009819999996)


   

Cys Met Asn Asp

(2S)-2-[(2S)-2-[(2S)-2-[(2R)-2-amino-3-sulfanylpropanamido]-4-(methylsulfanyl)butanamido]-3-carbamoylpropanamido]butanedioic acid

C16H27N5O8S2 (481.13009819999996)


   

Cys Asn Asp Met

(3S)-3-[(2S)-2-[(2R)-2-amino-3-sulfanylpropanamido]-3-carbamoylpropanamido]-3-{[(1S)-1-carboxy-3-(methylsulfanyl)propyl]carbamoyl}propanoic acid

C16H27N5O8S2 (481.13009819999996)


   

Cys Asn Met Asp

(2S)-2-[(2S)-2-[(2S)-2-[(2R)-2-amino-3-sulfanylpropanamido]-3-carbamoylpropanamido]-4-(methylsulfanyl)butanamido]butanedioic acid

C16H27N5O8S2 (481.13009819999996)


   

Cys Gln Cys Glu

(2S)-2-[(2R)-2-[(2S)-2-[(2R)-2-amino-3-sulfanylpropanamido]-4-carbamoylbutanamido]-3-sulfanylpropanamido]pentanedioic acid

C16H27N5O8S2 (481.13009819999996)


   

Cys Gln Glu Cys

(4S)-4-[(2S)-2-[(2R)-2-amino-3-sulfanylpropanamido]-4-carbamoylbutanamido]-4-{[(1R)-1-carboxy-2-sulfanylethyl]carbamoyl}butanoic acid

C16H27N5O8S2 (481.13009819999996)


   

Asp Cys Met Asn

(2S)-2-[(2S)-2-[(2R)-2-[(2S)-2-amino-3-carboxypropanamido]-3-sulfanylpropanamido]-4-(methylsulfanyl)butanamido]-3-carbamoylpropanoic acid

C16H27N5O8S2 (481.13009819999996)


   

Asp Cys Asn Met

(2S)-2-[(2S)-2-[(2R)-2-[(2S)-2-amino-3-carboxypropanamido]-3-sulfanylpropanamido]-3-carbamoylpropanamido]-4-(methylsulfanyl)butanoic acid

C16H27N5O8S2 (481.13009819999996)


   

Asp Met Cys Asn

(2S)-2-[(2R)-2-[(2S)-2-[(2S)-2-amino-3-carboxypropanamido]-4-(methylsulfanyl)butanamido]-3-sulfanylpropanamido]-3-carbamoylpropanoic acid

C16H27N5O8S2 (481.13009819999996)


   

Asp Met Asn Cys

(3S)-3-amino-3-{[(1S)-1-{[(1S)-2-carbamoyl-1-{[(1R)-1-carboxy-2-sulfanylethyl]carbamoyl}ethyl]carbamoyl}-3-(methylsulfanyl)propyl]carbamoyl}propanoic acid

C16H27N5O8S2 (481.13009819999996)


   

Asp Asn Cys Met

(2S)-2-[(2R)-2-[(2S)-2-[(2S)-2-amino-3-carboxypropanamido]-3-carbamoylpropanamido]-3-sulfanylpropanamido]-4-(methylsulfanyl)butanoic acid

C16H27N5O8S2 (481.13009819999996)


   

Asp Asn Met Cys

(3S)-3-amino-3-{[(1S)-2-carbamoyl-1-{[(1S)-1-{[(1R)-1-carboxy-2-sulfanylethyl]carbamoyl}-3-(methylsulfanyl)propyl]carbamoyl}ethyl]carbamoyl}propanoic acid

C16H27N5O8S2 (481.13009819999996)


   

Glu Cys Cys Gln

(2S)-2-[(2R)-2-[(2R)-2-[(2S)-2-amino-4-carboxybutanamido]-3-sulfanylpropanamido]-3-sulfanylpropanamido]-4-carbamoylbutanoic acid

C16H27N5O8S2 (481.13009819999996)


   

Glu Cys Gln Cys

(4S)-4-amino-4-{[(1R)-1-{[(1S)-3-carbamoyl-1-{[(1R)-1-carboxy-2-sulfanylethyl]carbamoyl}propyl]carbamoyl}-2-sulfanylethyl]carbamoyl}butanoic acid

C16H27N5O8S2 (481.13009819999996)


   

Glu Gln Cys Cys

(4S)-4-amino-4-{[(1S)-3-carbamoyl-1-{[(1R)-1-{[(1R)-1-carboxy-2-sulfanylethyl]carbamoyl}-2-sulfanylethyl]carbamoyl}propyl]carbamoyl}butanoic acid

C16H27N5O8S2 (481.13009819999996)


   

Met Cys Asp Asn

(3S)-3-[(2R)-2-[(2S)-2-amino-4-(methylsulfanyl)butanamido]-3-sulfanylpropanamido]-3-{[(1S)-2-carbamoyl-1-carboxyethyl]carbamoyl}propanoic acid

C16H27N5O8S2 (481.13009819999996)


   

Met Cys Asn Asp

(2S)-2-[(2S)-2-[(2R)-2-[(2S)-2-amino-4-(methylsulfanyl)butanamido]-3-sulfanylpropanamido]-3-carbamoylpropanamido]butanedioic acid

C16H27N5O8S2 (481.13009819999996)


   

Met Asp Cys Asn

(2S)-2-[(2R)-2-[(2S)-2-[(2S)-2-amino-4-(methylsulfanyl)butanamido]-3-carboxypropanamido]-3-sulfanylpropanamido]-3-carbamoylpropanoic acid

C16H27N5O8S2 (481.13009819999996)


   

Met Asp Asn Cys

(3S)-3-[(2S)-2-amino-4-(methylsulfanyl)butanamido]-3-{[(1S)-2-carbamoyl-1-{[(1R)-1-carboxy-2-sulfanylethyl]carbamoyl}ethyl]carbamoyl}propanoic acid

C16H27N5O8S2 (481.13009819999996)


   

Met Asn Cys Asp

(2S)-2-[(2R)-2-[(2S)-2-[(2S)-2-amino-4-(methylsulfanyl)butanamido]-3-carbamoylpropanamido]-3-sulfanylpropanamido]butanedioic acid

C16H27N5O8S2 (481.13009819999996)


   

Met Asn Asp Cys

(3S)-3-[(2S)-2-[(2S)-2-amino-4-(methylsulfanyl)butanamido]-3-carbamoylpropanamido]-3-{[(1R)-1-carboxy-2-sulfanylethyl]carbamoyl}propanoic acid

C16H27N5O8S2 (481.13009819999996)


   

Asn Cys Asp Met

(3S)-3-[(2R)-2-[(2S)-2-amino-3-carbamoylpropanamido]-3-sulfanylpropanamido]-3-{[(1S)-1-carboxy-3-(methylsulfanyl)propyl]carbamoyl}propanoic acid

C16H27N5O8S2 (481.13009819999996)


   

Asn Cys Met Asp

(2S)-2-[(2S)-2-[(2R)-2-[(2S)-2-amino-3-carbamoylpropanamido]-3-sulfanylpropanamido]-4-(methylsulfanyl)butanamido]butanedioic acid

C16H27N5O8S2 (481.13009819999996)


   

Asn Asp Cys Met

(2S)-2-[(2R)-2-[(2S)-2-[(2S)-2-amino-3-carbamoylpropanamido]-3-carboxypropanamido]-3-sulfanylpropanamido]-4-(methylsulfanyl)butanoic acid

C16H27N5O8S2 (481.13009819999996)


   

Asn Asp Met Cys

(3S)-3-[(2S)-2-amino-3-carbamoylpropanamido]-3-{[(1S)-1-{[(1R)-1-carboxy-2-sulfanylethyl]carbamoyl}-3-(methylsulfanyl)propyl]carbamoyl}propanoic acid

C16H27N5O8S2 (481.13009819999996)


   

Asn Met Cys Asp

(2S)-2-[(2R)-2-[(2S)-2-[(2S)-2-amino-3-carbamoylpropanamido]-4-(methylsulfanyl)butanamido]-3-sulfanylpropanamido]butanedioic acid

C16H27N5O8S2 (481.13009819999996)


   

Asn Met Asp Cys

(3S)-3-[(2S)-2-[(2S)-2-amino-3-carbamoylpropanamido]-4-(methylsulfanyl)butanamido]-3-{[(1R)-1-carboxy-2-sulfanylethyl]carbamoyl}propanoic acid

C16H27N5O8S2 (481.13009819999996)


   

Gln Cys Cys Glu

(2S)-2-[(2R)-2-[(2R)-2-[(2S)-2-amino-4-carbamoylbutanamido]-3-sulfanylpropanamido]-3-sulfanylpropanamido]pentanedioic acid

C16H27N5O8S2 (481.13009819999996)


   

Gln Cys Glu Cys

(4S)-4-[(2R)-2-[(2S)-2-amino-4-carbamoylbutanamido]-3-sulfanylpropanamido]-4-{[(1R)-1-carboxy-2-sulfanylethyl]carbamoyl}butanoic acid

C16H27N5O8S2 (481.13009819999996)


   

Gln Glu Cys Cys

(4S)-4-[(2S)-2-amino-4-carbamoylbutanamido]-4-{[(1R)-1-{[(1R)-1-carboxy-2-sulfanylethyl]carbamoyl}-2-sulfanylethyl]carbamoyl}butanoic acid

C16H27N5O8S2 (481.13009819999996)


   

6-(Methylsulfonyl)hexyl glucosinolate

{[(E)-(7-methanesulfonyl-1-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]sulfanyl}heptylidene)amino]oxy}sulfonic acid

C14H27NO11S3 (481.0746192)


   

silybin (mixture of silybin a and silybin b)

silybin (mixture of silybin a and silybin b)

C25H21O10 (481.11346660000004)


   

CefixiMe Ethyl Ester Sodium Salt

CefixiMe Ethyl Ester Sodium Salt

C18H19N5O7S2 (481.0725864)


   

1H-Pyrrolo[2,3-b]pyridine, 1-[(4-Methylphenyl)sulfonyl]-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-3-(2-thiazolyl)-

1H-Pyrrolo[2,3-b]pyridine, 1-[(4-Methylphenyl)sulfonyl]-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-3-(2-thiazolyl)-

C23H24BN3O4S2 (481.1301214)


   

fmoc-l-4-phosphonomethylphenylalanine

fmoc-l-4-phosphonomethylphenylalanine

C25H24NO7P (481.1290324)


   
   

Diethyl thiophosphoryl-(Z)-2-(2-aminothiazol-4-yl)-2-(tert-butoxycarbonyl)isopropoxyiminoacetate

Diethyl thiophosphoryl-(Z)-2-(2-aminothiazol-4-yl)-2-(tert-butoxycarbonyl)isopropoxyiminoacetate

C17H28N3O7PS2 (481.11062280000004)


   

1-Biotinylamino-3,6,9-trioxaundecane-11-bromide

1-Biotinylamino-3,6,9-trioxaundecane-11-bromide

C18H32BrN3O5S (481.12459220000005)


   

4-METHYLUMBELLIFERYL-2-ACETAMIDO-2-DEOXY-6-SULPHATE-β-D-GLUCOPYRANOSIDE

4-METHYLUMBELLIFERYL-2-ACETAMIDO-2-DEOXY-6-SULPHATE-β-D-GLUCOPYRANOSIDE

C18H20NNaO11S (481.065473)


   
   
   

Imidazol-3-ide;2-pyridin-2-ylpyridine;ruthenium(3+)

Imidazol-3-ide;2-pyridin-2-ylpyridine;ruthenium(3+)

C23H19N6Ru+2 (481.0714514)


   

Enloplatin [mart.]

Enloplatin [mart.]

C13H22N2O5Pt (481.1176492)


C274 - Antineoplastic Agent > C186664 - Cytotoxic Chemotherapeutic Agent > C2842 - DNA Binding Agent C274 - Antineoplastic Agent > C798 - Radiosensitizing Agent > C1450 - Platinum Compound

   

3-Benzoyloxypropyl glucosinolate

3-Benzoyloxypropyl glucosinolate

C17H23NO11S2 (481.0712488)


   
   
   
   

N-[1-[(4-bromoanilino)-oxomethyl]cyclohexyl]-N-(2-furanylmethyl)-2-pyridinecarboxamide

N-[1-[(4-bromoanilino)-oxomethyl]cyclohexyl]-N-(2-furanylmethyl)-2-pyridinecarboxamide

C24H24BrN3O3 (481.1000934)


   

4-[[1-[(3,4-Dichlorophenyl)methyl]-3-indolyl]-(3-methyl-5-oxo-1,2-dihydropyrazol-4-yl)methyl]-5-methyl-1,2-dihydropyrazol-3-one

4-[[1-[(3,4-Dichlorophenyl)methyl]-3-indolyl]-(3-methyl-5-oxo-1,2-dihydropyrazol-4-yl)methyl]-5-methyl-1,2-dihydropyrazol-3-one

C24H21Cl2N5O2 (481.1072226)


   

3-(1,3-benzodioxol-5-ylmethyl)-7-[1,4-dioxa-8-azaspiro[4.5]decan-8-yl(oxo)methyl]-2-sulfanylidene-1H-quinazolin-4-one

3-(1,3-benzodioxol-5-ylmethyl)-7-[1,4-dioxa-8-azaspiro[4.5]decan-8-yl(oxo)methyl]-2-sulfanylidene-1H-quinazolin-4-one

C24H23N3O6S (481.13074980000005)


   

N-[3-[(2,4-dimethylphenyl)sulfamoyl]-4-methylphenyl]-3-oxo-4H-1,4-benzothiazine-6-carboxamide

N-[3-[(2,4-dimethylphenyl)sulfamoyl]-4-methylphenyl]-3-oxo-4H-1,4-benzothiazine-6-carboxamide

C24H23N3O4S2 (481.11299180000003)


   

N-(3-cyano-6-methyl-4,5,6,7-tetrahydro-1-benzothiophen-2-yl)-5-phenyl-7-(trifluoromethyl)pyrazolo[1,5-a]pyrimidine-2-carboxamide

N-(3-cyano-6-methyl-4,5,6,7-tetrahydro-1-benzothiophen-2-yl)-5-phenyl-7-(trifluoromethyl)pyrazolo[1,5-a]pyrimidine-2-carboxamide

C24H18F3N5OS (481.1184094)


   

5-bromo-2-methoxy-3-methyl-N-[4-(4-methylsulfonyl-1-piperazinyl)phenyl]benzamide

5-bromo-2-methoxy-3-methyl-N-[4-(4-methylsulfonyl-1-piperazinyl)phenyl]benzamide

C20H24BrN3O4S (481.06708040000007)


   

Ethyl 4,5-dimethyl-2-[[2-(6-methyl-4-oxo-5-phenylthieno[2,3-d]pyrimidin-3-yl)acetyl]amino]thiophene-3-carboxylate

Ethyl 4,5-dimethyl-2-[[2-(6-methyl-4-oxo-5-phenylthieno[2,3-d]pyrimidin-3-yl)acetyl]amino]thiophene-3-carboxylate

C24H23N3O4S2 (481.11299180000003)


   

N-[[3-bromo-4-[(4-fluorophenyl)methoxy]-5-methoxyphenyl]methyl]-2-[(1-methyl-5-tetrazolyl)thio]ethanamine

N-[[3-bromo-4-[(4-fluorophenyl)methoxy]-5-methoxyphenyl]methyl]-2-[(1-methyl-5-tetrazolyl)thio]ethanamine

C19H21BrFN5O2S (481.05832780000003)


   

6-Hydroxydelphinidin 3-glucoside

6-Hydroxydelphinidin 3-glucoside

C21H21O13+ (481.0982116)


   

(3-oxo-1H-2-benzofuran-1-yl) (2S,5S,6R)-6-[[(2R)-2-amino-2-phenylacetyl]amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate

(3-oxo-1H-2-benzofuran-1-yl) (2S,5S,6R)-6-[[(2R)-2-amino-2-phenylacetyl]amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate

C24H23N3O6S (481.13074980000005)


   

[[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl] 2-methoxybenzoate

[[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl] 2-methoxybenzoate

C18H20N5O9P (481.0998600000001)


   

AGI-6780

AGI-6780

C21H18F3N3O3S2 (481.07416340000003)


AGI-6780 that potently and selectively inhibits the tumor-associated mutant IDH2R140Q with IC50 of 23±1.7 nM. AGI-6780 is less potent against IDH2WT with IC50 of 190±8.1 nM.

   

SB-399885 hydrochloride

SB-399885 hydrochloride

C18H22Cl3N3O4S (481.0396542000001)


SB-399885 hydrochloride is a 5-HT6 receptor antagonist.

   

UC2288

UC2288

C20H18ClF6N3O2 (481.09916699999997)


UC2288 is a novel, cell-permeable, and orally active p21 attenuator (relatively selective activity for p21), which is synthesized based Sorafenib (HY-10201). UC2288 decreases p21 mRNA expression independently of p53, and attenuates p21 protein levels with minimal effect on p21 protein stability. UC2288 has no inhibition of VEGFR2 and Raf kinases even at 10 μM[1].